Clinical Trial Update: Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of azacitidine in combination with thalidomide for higher-risk myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Thalidomide (Thalomid) (thalidomide)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: UNKNOWN